Gelehrter TD, Sznycer-Laszuk R, Zeheb R, Cwikel BJ. Dexa-methasone inhibition of tissue-type plasminogen activator (t-PA) activity: paradoxical induction of both t-PA antigen and plasminogen activator inhibitor. Molecular Endocrinology 1: 97–101, 1987 PubMedCASGoogle Scholar GISSI (Gruppo It...
Tissue plasminogen activator (tPA) is a drug given through a vein to help break up a blood clot so that blood flow can return to normal. It is used for the emergency treatment ofischemicstroke, which occurs when a blood clot interrupts blood flow to a region of the brain.1 The timely ...
英文名称:Recombinant Human Tissue Plasminogen Activator,tPA重组人组织纤维蛋白溶酶原激活剂总访问:394 国产/进口:进口半年访问:24 产地/品牌:美国Cali-bio产品类别:免疫学/诊断检测试剂 规格:CB500443最后更新:2024-12-5 货号: CAS 号: 参考报价:800
tissue type plasminogen activator (tPAurokinase (UKpro-urokinase (Pro-UKfibrinkringleIn view of the similarity of the charge distribution between fibrin A_伪148--161 and A chain 149--157 of urokinase,the latter might compete with fibrin A_伪148--161 when single chain pro-urokinase is ...
接收到Tissue Plasminogen Activator (tPA), Recombinant, Mouse (Biotin)产品后,置于-70°C温度下冻存;我们建议分装以避免反复冻融 其他 Usbiological公司是美国著名的抗体和生化试剂供应商,生产世界上种类最多的抗体,用于Western Blot、免疫沉淀、免疫荧光、免疫组化和流式细胞术等多种检测方法。Usbiological公司现已...
Because plasminogen activators (PA) may participate in the inflammatory process associated with the acute respiratory distress syndrome (ARDS), we measured the effect of tissue plasminogen activator (tPA) on inflammation and acute lung leak caused by intratracheal instillation of IL-1alpha (50 ng) ...
Tissue Plasminogen Activator (TPA) Antibody-BIOTIN 供应商 MyBioSource 产品货号 MBS851002 产品报价 ￥询价/0.1mg ￥询价/5x0.1mg ￥询价/其它规格 产品说明书 点击查看 购买方式 MyBioSource中国区金牌代理,部分产品现货库存。银行转账、电汇、支票、现金,在线支付宝及网银支付,或直接与我们电话联系400-6800-868...
网络组织纤溶酶原激活物 网络释义 1. 组织纤溶酶原激活物 ...asminogen Activator,UPA)或组织纤溶酶原激活物(Tissue-plasminogen Activator,TPA)将纤溶酶原转化为纤溶酶,纤溶酶 … www.wiki8.com|基于14个网页
从人的黑素瘤细胞提取总RNA,进行RT-PCR,克隆了组织纤维溶酶原激活剂(tPA)基因,对其缺失突变,进一步克隆了溶栓药物瑞替普酶-reteplase(rPA)基因;以羊的β-乳球蛋白基因(BLG)作为调控序列,构建了瑞替普酶的乳腺表达载体BrPA。6) reteplase 重组人组织型纤溶酶原激活剂突变体补充...
目的观察冠心病患者行冠状动脉介入治疗(PCI)手术前后血浆组织型纤溶酶原激活物(tPA)及纤溶酶原激活抑制剂(PAI)的动态变化。 2. Objective To explore the plasma concentration changes of tissue-type plasminogen activator(tPA),urokinasetype plasminogen activator(uPA),urokinasetype plasminogen activator receptor(uPA...